Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer

Por de Bruin-Visser, J. C., Ackerstaff, A. H., Rehorst, H., Retèl, V. P., Hilgers, F. J. M.
Publicado em 2011

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

Por Joosten, S.E.P., Retèl, V.P., Coupé, V.M.H., van den Heuvel, M.M., van Harten, W.H.
Publicado no BMC Cancer (2016)

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

Por Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Publicado em 2014

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

Por Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.
Publicado em 2014